The United Arab Emirates has become the first country in the world to approve a new medicine for the treatment of breast cancer. The development is being hailed as a significant achievement for cancer patients, especially those whose condition has become resistant to traditional hormone therapies.
According to media reports, the Emirates Drug Establishment has approved the use of “Itacama”, a drug that may help treat patients whose cancer cells have developed resistance to hormone therapy.
Experts say the key advantage of this new medicine is that it can be taken orally instead of being administered through injections, making the treatment process more convenient for patients. The drug works by blocking estrogen receptors in cancer cells, which helps slow down the growth and spread of cancer.
Medical specialists believe this medicine could bring new hope to patients who develop genetic changes during treatment and no longer respond effectively to existing hormone therapies.
The UAE’s approval of this drug is being considered an important milestone in the field of cancer treatment. Experts hope that other countries will also approve the medicine in the future, allowing more patients to access advanced treatment options.
